/PRNewswire/ BrickBio, the leader in RNA facilitated site-specific conjugation for novel protein therapeutics, will be presenting an invited poster at the.
/PRNewswire/ BrickBio, the leader in site-specific bioconjugation, announced a rapid next-generation conjugation chemistry, eCLICâ„¢ that will complement its.
/PRNewswire/ BrickBio, the leader in site specific bioconjugation has launched a collaboration SiteSelectâ„¢ Panel for pharmaceutical and drug development.